Popular Articles

InteKrin Therapeutics Announces INT131 Phase 2a Results At The 2009 American Diabetes Association Annual Meeting
InteKrin Therapeutics Inc presented Phase 2a clinical study results at the American Diabetes Association annual meeting in New Orleans demonstrating that once a day oral treatment with INT131 provides anti-diabetic efficacy consistent with maximal dose thiazolidinedione (TZD) therapy but with less hematocrit reduction and weight gain.

Innovotech Inc.: First-Ever Test Helps In Fight Against Serious Lung Infections And Opens Door For Treating Other Life-Threatening Infections
A new test developed by Edmonton-based Innovotech Inc. (TSX VENTURE:IOT) will now allow doctors to more accurately identify the right antibiotics required to treat serious, chronic infections that are biofilm based. With more than 80 per cent of infections in the developed world caused by biofilms, the potential for this new breakthrough test, called bioFILM PATM, is of immense significance to the medical community.
News of the day
Innovative Partnership Targets Cancer-Causing 'Chaperones'
Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) announced a major research collaboration with AstraZeneca. The three partners will combine their expertise to discover and develop potential new anti-cancer drugs to target molecular "chaperones" which support the growth of cancer cells.
Endocrinology

New Incentives Needed To Encourage GPs To Teach Medical Students, Australia

New strategies are needed to encourage general practitioners to teach medical students in their practices, according to a letter published in this year"s General Practice edition of the Medical Journal of Australia. Dr Mary-Louise Dick, Senior Lecturer in the School of Medicine at the University of Queensland, and her co-authors interviewed 55 Brisbane-based GPs who teach third-year University of Queensland medical students. "Many of the GPs said the rewards of teaching included the opportunity to showcase high-quality medical practice, the intellectual stimulation of having their practice observed and an appreciation that patients benefited from the participation of students in consultations," Dr Dick said. "Challenges cited included ensuring teaching responsibilities did not lead to longer waiting times for patients or interfere with their care. "Other problems included concerns about potential negative impacts on patients of inappropriate or inexpert student comments or skills and the extra demands of supervising relatively weak or apparently unenthusiastic students." "The difficulties of recruitment and retention of high-quality teaching practices in the current climate of general practice workforce shortage and increased medical student numbers are likely to increase, unless practice-based teaching remains manageable and rewarding," she said. "Strategies to promote and enhance the rewards of practice-based teaching, and overcome perceived obstacles including a lack of practice infrastructure, will be needed." GP Week runs from 20-26 July. The Medical Journal of Australia is a publication of the Australian Medical Association. Australian Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):